Skip to main content
. 2021 Jul 19;13(14):3608. doi: 10.3390/cancers13143608

Table 2.

GLO1 immunodetection during tumorigenic progression in arrayed prostate patient specimens.

Staining Scores 1 Adjacent Normal (n = 286) HGPIN
(n = 120)
Tumor
(n = 569)
Negative 12 (4.2%) 0 (0%) 3 (0.5%)
Weak 100 (35.2%) 18 (15%) 152 (27%)
Moderate 127 (44.7%) 23 (19.2%) 240 (42.6%)
Strong 45 (15.8%) 79 (65.8%) 169 (30%)
Total 284 120 564

1 H-score: weak (1–100); moderate (101–200); strong (201–300).